Search
Now showing items 1-3 of 3
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
Edelmann, Jennifer et al. (2020)
Wissenschaftlicher Artikel
Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways
Edelmann, Jennifer et al. (2021)
Wissenschaftlicher Artikel
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients
Bloehdorn, Johannes et al. (2022)
Wissenschaftlicher Artikel